PDL Guidance on the AstraZeneca COVID-19 Vaccine
The PDL Professional Officers have received several calls relating to the administration of the AstraZeneca (AZ) vaccine in patients below 60 years of age. Whilst the ATAGI advice regarding age
Not for profit
Owned by our pharmacist members for over 100 years
As well as Professional Indemnity Insurance, we notify our members of potential areas of risk and provide support if an incident occurs.
Our regular Practice Alerts notify members of common errors and incident trends, while the included subscription to the Australian Journal of Pharmacy (AJP) provides the latest profession news and research.
Earn CPD credits by accessing the hundreds of activities available from the AJP.
We collaborate with other key pharmacy bodies to support the wider pharmacy profession.
The PDL Professional Officers have received several calls relating to the administration of the AstraZeneca (AZ) vaccine in patients below 60 years of age. Whilst the ATAGI advice regarding age
There are certain medications that appear in notifications to PDL frequently. While some of these medications are considered low risk and have less potential for harm, it is important for
PDL has observed a recent trend in pharmacists being duped into supplying medication, usually S8 or S4s on fraudulent prescriptions by con artists who are becoming increasingly clever. A common